Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to Outperform from Perform, citing a favorable valuation setup ahead of a ...

Lilly partnered with Nektar on the drug in 2017, paying $150 million upfront with another $250 million at the back end in development and regulatory milestones. It has agreed to fund 75% of the ...

Find out more about how we test. The Ditto 2 is TC Electronic's new budget looper pedal. It replaces the ageing Ditto, a diminutive loop pedal that changed the game on its release. The Ditto offered ...

Good day, and thank you for standing by. Welcome to the Nektar Therapeutics Fourth Quarter 2024 financial results conference call. At this time, all participants are in a listen-only mode.

Nektar Therapeutics (NKTR) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of a loss of $0.13 per share. This compares to loss of $0.22 per share a year ago.

The fireside chat will be accessible via the webcast link above as well as on the Investor Events section of the Nektar website: https://ir.nektar.com/events-and ...

Nektar Therapeutics NKTR incurred an adjusted loss per share of 15 cents in the fourth quarter of 2024, wider than the Zacks Consensus Estimate of a loss of 13 cents. In the year-ago quarter, the ...

Tame the Web MIDI API. Send and receive MIDI messages with ease. Control instruments with user-friendly functions (playNote, sendPitchBend, etc.). React to MIDI input with simple event listeners ...

Whatever your reason for wanting pedal assistance – whether it makes cycling more accessible to you and your family or you think you'll have more fun with that boost – the e-bike market is ...